New Enterprise Associates

Kiswe Mobile, Inc. is a media packaging and technology company that specializes in live media solutions for sports and entertainment content owners. Founded in 2013 and headquartered in New Providence, New Jersey, Kiswe develops an application that allows users to discover, direct, watch, clip, and share live videos from their smartphones. The company's flagship product, CloudCast, leverages cloud-based technology to enhance the production and broadcasting of live events. Kiswe's solutions are utilized by major broadcasters, media companies, sports and eSports leagues, and music labels, including notable clients such as BTS, the NBA, and the PGA Tour. With additional offices in Europe and Asia, Kiswe aims to connect at-home viewers with live events and in-venue fans through interactive video experiences that foster social engagement and loyalty.

Nuvolo Technologies Corporation offers a cloud-based enterprise asset management platform built on the ServiceNow framework. Established in 2013 and headquartered in Paramus, New Jersey, with additional offices in London, Bulgaria, and India, Nuvolo specializes in life-cycle management solutions for assets in clinics, laboratories, facilities, and manufacturing sectors. The company provides a comprehensive suite of services that includes implementation, support, tracking, reporting, and analytics, aimed at enhancing the user experience for mobile and remote workforces. Known for its commitment to innovation and customer service, Nuvolo has formed strategic partnerships with major firms such as Atos, KPMG, and Unisys to further its mission of becoming a leader in cloud-based enterprise asset management.

Flow provides a turn-key platform for e-commerce companies to go global, capturing international demand for their products. The platform enables merchants to simply configure their cross-border supply-chain requirements and immediately fulfill their overseas demand. Flow can be used by e-commerce companies of any size and both as a complete, end-to-end solution or as a modular unbundled product. Using the Flow platform the experience of buying and selling internationally is as easy as domestic for both merchants and consumers.

Nuvolo Technologies Corporation offers a cloud-based enterprise asset management platform built on the ServiceNow framework. Established in 2013 and headquartered in Paramus, New Jersey, with additional offices in London, Bulgaria, and India, Nuvolo specializes in life-cycle management solutions for assets in clinics, laboratories, facilities, and manufacturing sectors. The company provides a comprehensive suite of services that includes implementation, support, tracking, reporting, and analytics, aimed at enhancing the user experience for mobile and remote workforces. Known for its commitment to innovation and customer service, Nuvolo has formed strategic partnerships with major firms such as Atos, KPMG, and Unisys to further its mission of becoming a leader in cloud-based enterprise asset management.

Oyster Point Pharma, Inc. is a clinical-stage biopharmaceutical company based in Princeton, New Jersey, that specializes in the discovery, development, and commercialization of innovative therapies for ocular surface diseases. Founded in 2015, the company is primarily focused on its lead product candidate, OC-01, a nicotinic acetylcholine receptor agonist currently undergoing Phase III clinical trials for the treatment of dry eye disease. This condition, which affects over 30 million Americans, is characterized by a chronic lack of sufficient tears, leading to discomfort and potential vision problems. OC-01 is developed as a nasal spray and aims to restore tear film homeostasis by activating the trigeminal parasympathetic pathway, thereby stimulating natural tear production. Additionally, the company is exploring the use of OC-01 for neurotrophic keratitis, further expanding its therapeutic potential in ocular health.

Oyster Point Pharma, Inc. is a clinical-stage biopharmaceutical company based in Princeton, New Jersey, that specializes in the discovery, development, and commercialization of innovative therapies for ocular surface diseases. Founded in 2015, the company is primarily focused on its lead product candidate, OC-01, a nicotinic acetylcholine receptor agonist currently undergoing Phase III clinical trials for the treatment of dry eye disease. This condition, which affects over 30 million Americans, is characterized by a chronic lack of sufficient tears, leading to discomfort and potential vision problems. OC-01 is developed as a nasal spray and aims to restore tear film homeostasis by activating the trigeminal parasympathetic pathway, thereby stimulating natural tear production. Additionally, the company is exploring the use of OC-01 for neurotrophic keratitis, further expanding its therapeutic potential in ocular health.

Nuvolo Technologies Corporation offers a cloud-based enterprise asset management platform built on the ServiceNow framework. Established in 2013 and headquartered in Paramus, New Jersey, with additional offices in London, Bulgaria, and India, Nuvolo specializes in life-cycle management solutions for assets in clinics, laboratories, facilities, and manufacturing sectors. The company provides a comprehensive suite of services that includes implementation, support, tracking, reporting, and analytics, aimed at enhancing the user experience for mobile and remote workforces. Known for its commitment to innovation and customer service, Nuvolo has formed strategic partnerships with major firms such as Atos, KPMG, and Unisys to further its mission of becoming a leader in cloud-based enterprise asset management.

Immunomedics, Inc. is a clinical-stage biopharmaceutical company based in Morris Plains, New Jersey, that focuses on developing monoclonal antibody-based therapies for cancer treatment. The company's lead product, sacituzumab govitecan, is an antibody-drug conjugate targeting metastatic triple-negative breast cancer, where it is positioned as a third-line treatment in the United States. Additionally, Immunomedics is advancing several other candidates, including IMMU-140 for hematologic malignancies and IMMU-130 for colorectal cancer. The company also explores collaborative clinical efforts with major pharmaceutical partners to enhance the development and application of its products. Founded in 1982, Immunomedics aims to deliver innovative treatments to patients with serious diseases, leveraging its capabilities to drive scientific advancements and operational effectiveness. As of late 2020, it operates as a subsidiary of Gilead Sciences, Inc.

Nuvolo Technologies Corporation offers a cloud-based enterprise asset management platform built on the ServiceNow framework. Established in 2013 and headquartered in Paramus, New Jersey, with additional offices in London, Bulgaria, and India, Nuvolo specializes in life-cycle management solutions for assets in clinics, laboratories, facilities, and manufacturing sectors. The company provides a comprehensive suite of services that includes implementation, support, tracking, reporting, and analytics, aimed at enhancing the user experience for mobile and remote workforces. Known for its commitment to innovation and customer service, Nuvolo has formed strategic partnerships with major firms such as Atos, KPMG, and Unisys to further its mission of becoming a leader in cloud-based enterprise asset management.

Champions Oncology, Inc. specializes in developing technology solutions and products aimed at personalizing the treatment of cancer. The company employs its Tumorgraft Technology Platform, which involves implanting human tumors in immune-deficient mice, to provide Personalized Oncology Solutions (POS). This platform enables physicians to tailor treatment options based on specific tumor data obtained from drug panels. Additionally, Champions Oncology offers Translational Oncology Solutions to assist pharmaceutical and biotechnology companies in their drug development processes. The company's product offerings include TumorGraft implants and drug panels that evaluate the response of a patient's tumor to various oncology drugs or combinations. Champions Oncology markets its products through online channels, referrals, and a dedicated sales team. Founded by leading experts in cancer research and treatment, the company is headquartered in Hackensack, New Jersey, and was incorporated in 1985.

Jet operates a smart shopping platform that allows its member to shop online from various retailers. It enables users to shop products in various categories, such as household products, health and beauty, grocery, baby, pet supplies, electronics, home and furniture, appliances, patio and garden, toys and video games, books, music and movies, office products, automotive, sports and fitness, clothing, shoes and accessories, jewelry and watches, arts, and crafts and hobbies. Mark Lore, Mike Hanrahan, and Nate Faust founded Jet in April 2014, with its headquarters in Hoboken in New Jersey. Jet operates as a subsidiary of Wal-Mart Stores as of September 19, 2016.

Jet operates a smart shopping platform that allows its member to shop online from various retailers. It enables users to shop products in various categories, such as household products, health and beauty, grocery, baby, pet supplies, electronics, home and furniture, appliances, patio and garden, toys and video games, books, music and movies, office products, automotive, sports and fitness, clothing, shoes and accessories, jewelry and watches, arts, and crafts and hobbies. Mark Lore, Mike Hanrahan, and Nate Faust founded Jet in April 2014, with its headquarters in Hoboken in New Jersey. Jet operates as a subsidiary of Wal-Mart Stores as of September 19, 2016.

Bravo Health, Inc. provides managed care services. It offers Medicare advantage options to allow members to choose the right plan for them; and special needs plans for those who are receiving institutional care, who have chronic health conditions, or who are eligible for both Medicare and Medicaid benefits. The company also provides private fee-for-service plans, which provide members the freedom to determine from whom they receive their health care; and part D prescription plans for those who only need coverage for their medications. It offers its plans to members in Delaware, Maryland, Pennsylvania, Texas, Washington, D.C., California, Florida, Illinois, Michigan, New Jersey, New York, Ohio, and West Virginia. Bravo Health, Inc. was formerly known as Elder Health, Inc. The company was founded in 1996 and is based in Baltimore, Maryland.

Roka Bioscience specializes in the development of rapid and accurate molecular assays and instrument systems aimed at the food safety industry. The company's latest innovation, the Atlas System, introduces advanced molecular rapid pathogen testing, which enhances laboratory efficiency through automation and user-friendly design. By focusing on innovative testing solutions, Roka Bioscience aims to assist food manufacturers in minimizing risks, safeguarding their brands, and addressing the growing demands for testing in the sector.

Roka Bioscience specializes in the development of rapid and accurate molecular assays and instrument systems aimed at the food safety industry. The company's latest innovation, the Atlas System, introduces advanced molecular rapid pathogen testing, which enhances laboratory efficiency through automation and user-friendly design. By focusing on innovative testing solutions, Roka Bioscience aims to assist food manufacturers in minimizing risks, safeguarding their brands, and addressing the growing demands for testing in the sector.

Omthera Pharmaceuticals, Inc. is an emerging specialty pharmaceuticals company focusing its efforts on the clinical development of new therapies for dyslipidemia. Led by a team of experts with exceptional experience in developing new therapies for lipid disorders, Omthera is dedicated to developing innovative therapies for the millions of patients who have elevated triglyceride levels and increased risk of cardiovascular disease.

Quidsi is one of the world's fastest growing e-commerce companies and parent of Diapers.com (baby care), Soap.com (household essentials) and BeautyBar.com (prestige beauty). The company's mission is to make life easier by creating a new type of e-commerce experience, delivering in 1-2 days, and providing incredible customer service. Quidsi is redefining e-commerce by combining the focus and customer connection of a specialty store with the scale, efficiency, choice, value and reliability of a massive global retailer.

Quidsi is one of the world's fastest growing e-commerce companies and parent of Diapers.com (baby care), Soap.com (household essentials) and BeautyBar.com (prestige beauty). The company's mission is to make life easier by creating a new type of e-commerce experience, delivering in 1-2 days, and providing incredible customer service. Quidsi is redefining e-commerce by combining the focus and customer connection of a specialty store with the scale, efficiency, choice, value and reliability of a massive global retailer.

Antenna Software provides the most complete cloud-based enterprise mobility suite in the market, enabling both IT pros and business executives alike to create and manage mobile apps, websites, and content across the entire business. AMPchromaTM gives Global 1000 companies the ability to create, control, measure, adapt, and future-proof their mobile business strategies for employees, partners, and customers in one place, increasing productivity, connectivity, and engagement. Antenna's integrated suite of mobile services provides unparalleled creativity, control, and visibility throughout the entire mobile value chain. Founded in 1998, Antenna is headquartered in Jersey City, N.J., with offices around the world.

Esprit Pharma is a pharmaceutical company focused on specialty therapeutics and committed to improving patient well-being in the urology and OB/GYN areas by providing products that contribute to bettering patient outcomes.

Amicus Therapeutics, Inc., a biotechnology company, engages in the discovery, development, and commercialization of therapies to treat a range of rare and orphan diseases. The company offers Galafold, an orally administered small molecule pharmacological chaperone for the treatment of Fabry disease. It is also conducting Phase 3 (ATB200-03) clinical study of AT-GAA for Pompe disease. The company has collaboration and license agreements with Nationwide Children's Hospital and University of Pennsylvania. Amicus Therapeutics, Inc. was founded in 2002 and is headquartered in Cranbury, New Jersey.

Esprit Pharma is a pharmaceutical company focused on specialty therapeutics and committed to improving patient well-being in the urology and OB/GYN areas by providing products that contribute to bettering patient outcomes.

Amicus Therapeutics, Inc., a biotechnology company, engages in the discovery, development, and commercialization of therapies to treat a range of rare and orphan diseases. The company offers Galafold, an orally administered small molecule pharmacological chaperone for the treatment of Fabry disease. It is also conducting Phase 3 (ATB200-03) clinical study of AT-GAA for Pompe disease. The company has collaboration and license agreements with Nationwide Children's Hospital and University of Pennsylvania. Amicus Therapeutics, Inc. was founded in 2002 and is headquartered in Cranbury, New Jersey.

Esprit Pharma is a pharmaceutical company focused on specialty therapeutics and committed to improving patient well-being in the urology and OB/GYN areas by providing products that contribute to bettering patient outcomes.

Through nearly 20 years of constant change and disruption in the technology space, Vonage has been leading through the change. With this brand revitalization, Vonage is demonstrating its position as a B2B communications SaaS leader for a new era. - Scales to serve its customers globally with unrivalled capabilities integrating voice, messaging, video and data, built on a carrier-grade network infrastructure. - Offers uniquely flexible portfolio of proven, ready-to-go applications, or use of extensive communications APIs to create proprietary applications and integrations, or takes the best of both, using apps and customizing with APIs. - Enables businesses to have great conversations everywhere, to effortlessly create new and differentiated experiences, and like never before, unlock the power of data and AI to make every conversation more successful.

Through nearly 20 years of constant change and disruption in the technology space, Vonage has been leading through the change. With this brand revitalization, Vonage is demonstrating its position as a B2B communications SaaS leader for a new era. - Scales to serve its customers globally with unrivalled capabilities integrating voice, messaging, video and data, built on a carrier-grade network infrastructure. - Offers uniquely flexible portfolio of proven, ready-to-go applications, or use of extensive communications APIs to create proprietary applications and integrations, or takes the best of both, using apps and customizing with APIs. - Enables businesses to have great conversations everywhere, to effortlessly create new and differentiated experiences, and like never before, unlock the power of data and AI to make every conversation more successful.

Amicus Therapeutics, Inc., a biotechnology company, engages in the discovery, development, and commercialization of therapies to treat a range of rare and orphan diseases. The company offers Galafold, an orally administered small molecule pharmacological chaperone for the treatment of Fabry disease. It is also conducting Phase 3 (ATB200-03) clinical study of AT-GAA for Pompe disease. The company has collaboration and license agreements with Nationwide Children's Hospital and University of Pennsylvania. Amicus Therapeutics, Inc. was founded in 2002 and is headquartered in Cranbury, New Jersey.

Through nearly 20 years of constant change and disruption in the technology space, Vonage has been leading through the change. With this brand revitalization, Vonage is demonstrating its position as a B2B communications SaaS leader for a new era. - Scales to serve its customers globally with unrivalled capabilities integrating voice, messaging, video and data, built on a carrier-grade network infrastructure. - Offers uniquely flexible portfolio of proven, ready-to-go applications, or use of extensive communications APIs to create proprietary applications and integrations, or takes the best of both, using apps and customizing with APIs. - Enables businesses to have great conversations everywhere, to effortlessly create new and differentiated experiences, and like never before, unlock the power of data and AI to make every conversation more successful.

Leapstone Systems, Inc. provides communication software solutions to network operators in the United States. The company offers Communications Convergence Engine that is a software platform, which enables operators to design, package, deploy, and manage a range of compelling content and services. Its products include CCE serviceBROKER's, which enables operators to integrate various services, including voice, IPTV,

PPONEXT is a PPO services company that provides healthcare management and network services. PPONEXT offers access to a network of medical care providers, hospitals, and ancillary facilities to group health, workers' compensation, and other insurance payers in the Midwest, Texas, California, Florida, New Jersey, and Pennsylvania.

Sonic mission by putting into practice three corporate values. These standards are the driving force behind our solutions and provide focus as we meet the needs of professionals and users. We manufacture quality hearing aids and are all about celebrating the sounds of everyday life like music, nature, and more. With Sonic, everyday sounds better.